Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Velmanase alfa (Lamzede)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-04 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vedolizumab (Entyvio) for Injection for Intravenous UsePayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-18 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vectra DA Blood Test for Rheumatoid ArthritisPayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-45 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Valoctocogene roxaparvovec-rvox (ROCTAVIAN)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-09 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vagus Nerve Stimulation (VNS)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-15-16 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Uterine Artery EmbolizationPayerPolicy · AMERIHEALTH-COMMERCIAL-11-06-04 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ustekinumab for Intravenous InfusionPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-82Q-344348E2F7 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Use of a Robotic-Assisted Surgical SystemPayerPolicy · AMERIHEALTH-COMMERCIAL-11-00-18 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Upper Limb ProsthesesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-72 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ultraviolet Light Therapy for the Treatment of Dermatological ConditionsPayerPolicy · AMERIHEALTH-COMMERCIAL-07-07-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ublituximab-xiiy (Briumvi) for intravenous usePayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tumor Treating FieldsPayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-26 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trilaciclib (Cosela)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-77 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trigger Point InjectionsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Triamcinolone Acetonide Extended-Release Injectable (Zilretta)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-47 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatments for Complex Regional Pain Syndrome (CRPS)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-57V-BB8AE1D715 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Varicose Veins of the Lower Extremities and Perforator Vein IncompetencePayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic AgentsPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-25 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Obstructive Sleep Apnea (OSA) and Primary SnoringPayerPolicy · AMERIHEALTH-COMMERCIAL-11-00-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Medical and Surgical ComplicationsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-00-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trastuzumab (Herceptin) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-33 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-74 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcatheter Cardiac Valve ProceduresPayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-25 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcatheter Arterial Chemoembolization (TACE) of Hepatic MalignanciesPayerPolicy · AMERIHEALTH-COMMERCIAL-07-05-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Total Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN) / Intraperitoneal Parenteral Nutrition (IPN)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-17 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Toripalimab-tpzi (Loqtorzi)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-20 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tofersen (Qalsody)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tocilizumab and Related Biosimilars for Intravenous InfusionPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-85T-0EF19283B0 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tisotumab vedotin-tftv (Tivdak)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-83 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tislelizumab-jsgr (Tevimbra)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-23 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tildrakizumab-asmn (Ilumya)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-48B-331266F9C8 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapies for Spinal Muscular Atrophy Nusinersen (Spinraza) and Onasemnogene abeparvovec-xioi (Zolgensma)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-36H-3CFA7A4C1A | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic Transcranial Magnetic Stimulation (TMS)PayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-22 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic Shoes and Orthopedic ShoesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-11 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or AntiepilepticsPayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-55 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Testing Serum Vitamin D LevelsPayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-51 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teprotumumab-trbw (Tepezza)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-41 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teplizumab-mzwv (Tzield)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-99 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Telisotuzumab vedotin-tllv (Emrelis)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-45 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Telemedicine ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-10-41 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Telemedicine and Telehealth Services for AmeriHealth New Jersey MembersPayerPolicy · AMERIHEALTH-COMMERCIAL-00-10-42-NEW-JERSEY | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teclistamab-cqyv (Tecvayli)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-98 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tebentafusp-tebn (Kimmtrak)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-85 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tarlatamab-dlle (Imdelltra) for intravenous usePayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-27 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Talquetamab-tgvs (Talvey)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-16 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tafasitamab-cxix (Monjuvi)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-81 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sutimlimab-jome (Enjaymo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-87 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Treatments of Athletic PubalgiaPayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-26 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Treatment of Femoroacetabular Impingement (Amerihealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-23 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Procedures of the Eyelid and BrowPayerPolicy · AMERIHEALTH-COMMERCIAL-11-05-02 | New policy |
|---|